Rare Diseases

108 Employers in 177 locations

Employers working on Rare Diseases work in 79 other areas

Displaying 1 - 15 of 79 related areas

Locale
Careers
Internships

Displaying 1 - 60 of 108 employers

Only three business areas are listed for each employer.

Description
Developing genetic tests to detect rare diseases.

Description
The company has developed technology that for producing adeno-associated virus ...

Business Area(s)
Description
Abliva develops mitochondrial medicine. They have one project in clinical phase ...

Business Area(s)
Description
Adrestia Therapeutics is using genetic networks to reveal new ways to treat ...

Description
Agios works on cellular metabolism and precision medicine across three major ...

Description
Alexion Pharmaceuticals is part of Astra Zeneca and is developing treatments for ...

Business Area(s)
Description
Alnylam develops innovative RNAi-based medicines in four therapeutic areas ...

Description
Amicus Therapeutics is a global, biotech company focused on discovering ...

Business Area(s)
Description
Developing treatments for Epidermolysis Bullosa, a group of rare and genetic ...

Description
Gene Therapy for Friedrich's ataxia

Business Area(s)
Description
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a ...

Description
The company is working to develop products that address rare endocrine diseases ...

Business Area(s)
Description
AskBio is a subsidiary of Bayer AG. The company develops cell and gene therapies ...

Description
Cerecor is building a global biopharmaceutical enterprise with a near-term ...

Description
Azafaros was founded in 2018 to address rare genetic metabolic disorders through ...

Description
Beacon Therapeutics is developing genetic therapies to treat patients with rare ...

Business Area(s)
Description
Generics & 505(b)(2) drugs

Description
BioCryst develops drugs to treat rare diseases. Galidesivir (BCX4430), an anti ...

Description
Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage ...

Description
Small Molecules

Description
BioMarin focuses on developing therapeutics for patients who live with serious ...

Description
BioXcel is a biopharmaceutical company that uses artificial intelligence and big ...

Description
BOOST Pharma focuses on high-bone-forming, allogeneic cell therapies for rare ...

Business Area(s)
Description
Bridgebio is a collection of individuals focused on discovering and developing ...

Description
Caraway Therapeutics is pursuing approaches for the treatment of debilitating ...

Description
Castle Creek Biosciences, Inc., a clinical-stage cell and gene therapy company ...

Business Area(s)
Description
Castle Creek Pharma is a biopharmaceutical company with a focus on the treatment ...

Description
CENTOGENE develops tests for the genetic diagnostics for rare hereditary ...

Description
Chiesi Farmaceutici S.p.A. is an Italian family controlled global pharmaceutical ...

Description
Chromocell is focused on the discovery and development of therapeutics and ...

Business Area(s)
Description
505(b)(2) drugs

Description
Coave Therapeutics is a clinical stage biotechnology company focused on ...

Description
Code Bio is developing next-generation gene therapies for patients with rare and ...

Description
Collaborations Pharmaceuticals, Inc.® performs research and development on ...

Description
Constant is a clinical stage company developing Mas receptor agonists for ...

CSL

Business Area(s)
Description
CSL is a global biotechnology company with a dynamic portfolio of lifesaving ...

Business Area(s)
Description
CSL Behring is a biopharmaceutical company that manufactures plasma-derived and ...

Business Area(s)
Description
CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that ...

Business Area(s)
Description
Cyclerion was founded with the goal of unlocking the full therapeutic potential ...

Business Area(s)
Description
Egetis is a pharmaceutical company, focusing on projects in late-stage ...

Description
The company is investigating how the ZSCAN4 gene might be useful in cell ...

Business Area(s)
Description
Emalex Biosciences develops treatments for central nervous system movement ...

Description
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the ...

Description
EpiSignâ„¢ is a clinically validated test that analyzes genomic DNA methylation ...

Description
Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical ...

Description
Exegenesis Bio is a clinical-stage global cell and gene therapy company that ...

Business Area(s)
Description
Early-stage research on 505(b)(2) products

Description
GeneDx provides genomics testing with expertise in rare and ultra-rare genetic ...

Description
Gene Therapy

Business Area(s)
Description
Grace Therapeutics is a late-stage biopharma company with drug candidates ...

Description
The company is working to develop lifesaving and life altering therapies for ...

Description
Harmony Biosciences, LLC, is a private biopharmaceutical company headquartered ...

Description
HBM Alpha Therapeutics. HBM Alpha Therapeutics is a company presently developing ...

Description
Developed an AI platform for rare disease drug discovery.

Description
Homology Medicines is working to use gene editing and gene therapy to bring new ...

Description
Developing a drug discovery platform for allosteric medicines.

Description
Engineers B cells through gene therapy to produce proteins that combat disease ...

Business Area(s)
Description
The mission of Infixion Bioscience is to develop treatments to eradicate NF1, a ...

Description
The company is working on an in vivo gene-editing therapy for the treatment of ...

Business Area(s)
Description
IntraBio Inc. is focused on the development and commercialization of drugs for ...